Global Diagnostic Nuclear Drug Market Research Report 2025(Status and Outlook)

March 2025 | 219 pages | ID: GE0682A6F146EN
Bosson Research

Abstracts

Report Overview

Nuclear Drugs are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis

This report provides a deep insight into the global Diagnostic Nuclear Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Diagnostic Nuclear Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Diagnostic Nuclear Drug market in any manner.

Global Diagnostic Nuclear Drug Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Cardinal Health

GE Healthcare

Curium Pharma

Jubilant Pharma

Bracco Imaging

Novartis

SIEMENS

China Isotope & Radiation

Dongcheng

Lantheus

Eli Lilly

Market Segmentation (by Type)

Tc-99m

F-18

Other

Market Segmentation (by Application)

Oncology

Cardiology

Other

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Diagnostic Nuclear Drug Market
• Overview of the regional outlook of the Diagnostic Nuclear Drug Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Diagnostic Nuclear Drug Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Diagnostic Nuclear Drug
1.2 Key Market Segments
  1.2.1 Diagnostic Nuclear Drug Segment by Type
  1.2.2 Diagnostic Nuclear Drug Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 GLOBAL DIAGNOSTIC NUCLEAR DRUG MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Diagnostic Nuclear Drug Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global Diagnostic Nuclear Drug Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 GLOBAL DIAGNOSTIC NUCLEAR DRUG MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Diagnostic Nuclear Drug Product Life Cycle
3.3 Global Diagnostic Nuclear Drug Sales by Manufacturers (2020-2025)
3.4 Global Diagnostic Nuclear Drug Revenue Market Share by Manufacturers (2020-2025)
3.5 Diagnostic Nuclear Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Diagnostic Nuclear Drug Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Diagnostic Nuclear Drug Manufacturing Sites, Area Served, Product Type
3.8 Diagnostic Nuclear Drug Market Competitive Situation and Trends
  3.8.1 Diagnostic Nuclear Drug Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Diagnostic Nuclear Drug Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 DIAGNOSTIC NUCLEAR DRUG INDUSTRY CHAIN ANALYSIS

4.1 Diagnostic Nuclear Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF DIAGNOSTIC NUCLEAR DRUG MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Diagnostic Nuclear Drug Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 Global Trade Frictions and Their Impacts to Diagnostic Nuclear Drug Market
5.7 ESG Ratings of Leading Companies

6 GLOBAL DIAGNOSTIC NUCLEAR DRUG MARKET BY REGION

6.1 Global Diagnostic Nuclear Drug Market Size by Region
  6.1.1 Global Diagnostic Nuclear Drug Market Size by Region
  6.1.2 Global Diagnostic Nuclear Drug Market Size Market Share by Region
6.2 Global Diagnostic Nuclear Drug Sales by Region
  6.2.1 Global Diagnostic Nuclear Drug Sales by Region
  6.2.2 Global Diagnostic Nuclear Drug Sales Market Share by Region

7 NORTH AMERICA MARKET OVERVIEW

7.1 North America Diagnostic Nuclear Drug Market Size by Country
  7.1.1 USA Market Overview
  7.1.2 Canada Market Overview
  7.1.3 Mexico Market Overview
7.2 North America Diagnostic Nuclear Drug Market Size by Type
7.3 North America Diagnostic Nuclear Drug Market Size by Application

8 EUROPE MARKET OVERVIEW

8.1 Europe Diagnostic Nuclear Drug Market Size by Country
  8.1.1 Germany Market Overview
  8.1.2 France Market Overview
  8.1.3 U.K. Market Overview
  8.1.4 Italy Market Overview
  8.1.5 Spain Market Overview
8.2 Europe Diagnostic Nuclear Drug Market Size by Type
8.3 Europe Diagnostic Nuclear Drug Market Size by Application

9 ASIA-PACIFIC MARKET OVERVIEW

9.1 Asia-Pacific Diagnostic Nuclear Drug Market Size by Country
  9.1.1 China Market Overview
  9.1.2 Japan Market Overview
  9.1.3 South Korea Market Overview
  9.1.4 India Market Overview
  9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Diagnostic Nuclear Drug Market Size by Type
9.3 Asia-Pacific Diagnostic Nuclear Drug Market Size by Application

10 SOUTH AMERICA MARKET OVERVIEW

10.1 South America Diagnostic Nuclear Drug Market Size by Country
  10.1.1 Brazil Market Overview
  10.1.2 Argentina Market Overview
  10.1.3 Columbia Market Overview
10.2 South America Diagnostic Nuclear Drug Market Size by Type
10.3 South America Diagnostic Nuclear Drug Market Size by Application

11 MIDDLE EAST AND AFRICA MARKET OVERVIEW

11.1 Middle East and Africa Diagnostic Nuclear Drug Market Size by Country
  11.1.1 Saudi Arabia Market Overview
  11.1.2 UAE Market Overview
  11.1.3 Egypt Market Overview
  11.1.4 Nigeria Market Overview
  11.1.5 South Africa Market Overview
11.2 Middle East and Africa Diagnostic Nuclear Drug Market Size by Type
11.3 Middle East and Africa Diagnostic Nuclear Drug Market Size by Application

12 DIAGNOSTIC NUCLEAR DRUG MARKET PRODUCTION BY REGION

12.1 Global Production of Diagnostic Nuclear Drug by Region(2020-2025)
12.2 Global Diagnostic Nuclear Drug Revenue Market Share by Region (2020-2025)
12.3 Global Diagnostic Nuclear Drug Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Diagnostic Nuclear Drug Production
  12.4.1 North America Diagnostic Nuclear Drug Production Growth Rate (2020-2025)
  12.4.2 North America Diagnostic Nuclear Drug Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Diagnostic Nuclear Drug Production
  12.5.1 Europe Diagnostic Nuclear Drug Production Growth Rate (2020-2025)
  12.5.2 Europe Diagnostic Nuclear Drug Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Diagnostic Nuclear Drug Production (2020-2025)
  12.6.1 Japan Diagnostic Nuclear Drug Production Growth Rate (2020-2025)
  12.6.2 Japan Diagnostic Nuclear Drug Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Diagnostic Nuclear Drug Production (2020-2025)
  12.7.1 China Diagnostic Nuclear Drug Production Growth Rate (2020-2025)
  12.7.2 China Diagnostic Nuclear Drug Production, Revenue, Price and Gross Margin (2020-2025)

13 DIAGNOSTIC NUCLEAR DRUG MARKET SEGMENTATION BY TYPE

13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Diagnostic Nuclear Drug Sales Market Share by Type (2020-2033)
13.3 Global Diagnostic Nuclear Drug Market Size Market Share by Type (2020-2033)
13.4 Global Diagnostic Nuclear Drug Price by Type (2020-2033)

14 DIAGNOSTIC NUCLEAR DRUG MARKET SEGMENTATION BY APPLICATION

14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Diagnostic Nuclear Drug Market Sales by Application (2020-2033)
14.3 Global Diagnostic Nuclear Drug Market Size (M USD) by Application (2020-2033)
14.4 Global Diagnostic Nuclear Drug Sales Growth Rate by Application (2020-2033)

15 KEY COMPANIES PROFILE

15.1 Cardinal Health
  15.1.1 Cardinal Health Basic Information
  15.1.2 Cardinal Health Diagnostic Nuclear Drug Product Overview
  15.1.3 Cardinal Health Diagnostic Nuclear Drug Product Market Performance
  15.1.4 Cardinal Health Business Overview
  15.1.5 Cardinal Health SWOT Analysis
  15.1.6 Cardinal Health Recent Developments
15.2 GE Healthcare
  15.2.1 GE Healthcare Basic Information
  15.2.2 GE Healthcare Diagnostic Nuclear Drug Product Overview
  15.2.3 GE Healthcare Diagnostic Nuclear Drug Product Market Performance
  15.2.4 GE Healthcare Business Overview
  15.2.5 GE Healthcare SWOT Analysis
  15.2.6 GE Healthcare Recent Developments
15.3 Curium Pharma
  15.3.1 Curium Pharma Basic Information
  15.3.2 Curium Pharma Diagnostic Nuclear Drug Product Overview
  15.3.3 Curium Pharma Diagnostic Nuclear Drug Product Market Performance
  15.3.4 Curium Pharma Business Overview
  15.3.5 Curium Pharma SWOT Analysis
  15.3.6 Curium Pharma Recent Developments
15.4 Jubilant Pharma
  15.4.1 Jubilant Pharma Basic Information
  15.4.2 Jubilant Pharma Diagnostic Nuclear Drug Product Overview
  15.4.3 Jubilant Pharma Diagnostic Nuclear Drug Product Market Performance
  15.4.4 Jubilant Pharma Business Overview
  15.4.5 Jubilant Pharma Recent Developments
15.5 Bracco Imaging
  15.5.1 Bracco Imaging Basic Information
  15.5.2 Bracco Imaging Diagnostic Nuclear Drug Product Overview
  15.5.3 Bracco Imaging Diagnostic Nuclear Drug Product Market Performance
  15.5.4 Bracco Imaging Business Overview
  15.5.5 Bracco Imaging Recent Developments
15.6 Novartis
  15.6.1 Novartis Basic Information
  15.6.2 Novartis Diagnostic Nuclear Drug Product Overview
  15.6.3 Novartis Diagnostic Nuclear Drug Product Market Performance
  15.6.4 Novartis Business Overview
  15.6.5 Novartis Recent Developments
15.7 SIEMENS
  15.7.1 SIEMENS Basic Information
  15.7.2 SIEMENS Diagnostic Nuclear Drug Product Overview
  15.7.3 SIEMENS Diagnostic Nuclear Drug Product Market Performance
  15.7.4 SIEMENS Business Overview
  15.7.5 SIEMENS Recent Developments
15.8 China Isotope and Radiation
  15.8.1 China Isotope and Radiation Basic Information
  15.8.2 China Isotope and Radiation Diagnostic Nuclear Drug Product Overview
  15.8.3 China Isotope and Radiation Diagnostic Nuclear Drug Product Market Performance
  15.8.4 China Isotope and Radiation Business Overview
  15.8.5 China Isotope and Radiation Recent Developments
15.9 Dongcheng
  15.9.1 Dongcheng Basic Information
  15.9.2 Dongcheng Diagnostic Nuclear Drug Product Overview
  15.9.3 Dongcheng Diagnostic Nuclear Drug Product Market Performance
  15.9.4 Dongcheng Business Overview
  15.9.5 Dongcheng Recent Developments
15.10 Lantheus
  15.10.1 Lantheus Basic Information
  15.10.2 Lantheus Diagnostic Nuclear Drug Product Overview
  15.10.3 Lantheus Diagnostic Nuclear Drug Product Market Performance
  15.10.4 Lantheus Business Overview
  15.10.5 Lantheus Recent Developments
15.11 Eli Lilly
  15.11.1 Eli Lilly Basic Information
  15.11.2 Eli Lilly Diagnostic Nuclear Drug Product Overview
  15.11.3 Eli Lilly Diagnostic Nuclear Drug Product Market Performance
  15.11.4 Eli Lilly Business Overview
  15.11.5 Eli Lilly Recent Developments

16 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Diagnostic Nuclear Drug Market Size by Type (M USD)
Table 4. Global Diagnostic Nuclear Drug Market Size by Application (M USD)
Table 5. Diagnostic Nuclear Drug Market Size Comparison by Region (M USD)
Table 6. Global Diagnostic Nuclear Drug Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Diagnostic Nuclear Drug Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Diagnostic Nuclear Drug Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Diagnostic Nuclear Drug Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Nuclear Drug as of 2024)
Table 11. Global Market Diagnostic Nuclear Drug Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Diagnostic Nuclear Drug Manufacturing Sites and Area Served
Table 13. Manufacturers Diagnostic Nuclear Drug Product Type
Table 14. Global Diagnostic Nuclear Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Diagnostic Nuclear Drug Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Diagnostic Nuclear Drug Market Size Comparison by Region (M USD)
Table 26. Global Diagnostic Nuclear Drug Market Size by Region (2020-2033) & (M USD)
Table 27. Global Diagnostic Nuclear Drug Market Size Market Share by Region (2020-2033)
Table 28. Global Diagnostic Nuclear Drug Sales by Region (2020-2033) & (K MT)
Table 29. Global Diagnostic Nuclear Drug Sales Market Share by Region (2020-2033)
Table 30. North America Diagnostic Nuclear Drug Market Size by Country (2020-2033) & (M USD)
Table 31. North America Diagnostic Nuclear Drug Sales by Country (2020-2033) & (K MT)
Table 32. North America Diagnostic Nuclear Drug Sales by Type (K MT)
Table 33. North America Diagnostic Nuclear Drug Market Size by Type (M USD)
Table 34. North America Diagnostic Nuclear Drug Sales (K MT) by Type (2020-2033)
Table 35. North America Diagnostic Nuclear Drug Market Size (M USD) by Type (2020-2033)
Table 36. North America Diagnostic Nuclear Drug Sales by Application (K MT)
Table 37. North America Diagnostic Nuclear Drug Market Size by Application (M USD)
Table 38. North America Diagnostic Nuclear Drug Sales (K MT) by Application (2020-2033)
Table 39. North America Diagnostic Nuclear Drug Market Size (M USD) by Application (2020-2033)
Table 40. Europe Diagnostic Nuclear Drug Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Diagnostic Nuclear Drug Sales by Country (2020-2033) & (K MT)
Table 42. Europe Diagnostic Nuclear Drug Sales by Type (K MT)
Table 43. Europe Diagnostic Nuclear Drug Market Size by Type (M USD)
Table 44. Europe Diagnostic Nuclear Drug Sales (K MT) by Type (2020-2033)
Table 45. Europe Diagnostic Nuclear Drug Market Size (M USD) by Type (2020-2033)
Table 46. Europe Diagnostic Nuclear Drug Sales by Application (K MT)
Table 47. Europe Diagnostic Nuclear Drug Market Size by Application (M USD)
Table 48. Europe Diagnostic Nuclear Drug Sales (K MT) by Application (2020-2033)
Table 49. Europe Diagnostic Nuclear Drug Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Diagnostic Nuclear Drug Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Diagnostic Nuclear Drug Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific Diagnostic Nuclear Drug Sales by Type (K MT)
Table 53. Asia-Pacific Diagnostic Nuclear Drug Market Size by Type (M USD)
Table 54. Asia-Pacific Diagnostic Nuclear Drug Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific Diagnostic Nuclear Drug Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Diagnostic Nuclear Drug Sales by Application (K MT)
Table 57. Asia-Pacific Diagnostic Nuclear Drug Market Size by Application (M USD)
Table 58. Asia-Pacific Diagnostic Nuclear Drug Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific Diagnostic Nuclear Drug Market Size (M USD) by Application (2020-2025)
Table 60. South America Diagnostic Nuclear Drug Market Size by Country (2020-2033) & (M USD)
Table 61. South America Diagnostic Nuclear Drug Sales by Country (2020-2033) & (K MT)
Table 62. South America Diagnostic Nuclear Drug Sales by Type (K MT)
Table 63. South America Diagnostic Nuclear Drug Market Size by Type (M USD)
Table 64. South America Diagnostic Nuclear Drug Sales (K MT) by Type (2020-2033)
Table 65. South America Diagnostic Nuclear Drug Market Size (M USD) by Type (2020-2033)
Table 66. South America Diagnostic Nuclear Drug Sales by Application (K MT)
Table 67. South America Diagnostic Nuclear Drug Market Size by Application (M USD)
Table 68. South America Diagnostic Nuclear Drug Sales (K MT) by Application (2020-2033)
Table 69. South America Diagnostic Nuclear Drug Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Diagnostic Nuclear Drug Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Diagnostic Nuclear Drug Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa Diagnostic Nuclear Drug Sales by Type (K MT)
Table 73. Middle East and Africa Diagnostic Nuclear Drug Market Size by Type (M USD)
Table 74. Middle East and Africa Diagnostic Nuclear Drug Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa Diagnostic Nuclear Drug Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Diagnostic Nuclear Drug Sales by Application (K MT)
Table 77. Middle East and Africa Diagnostic Nuclear Drug Market Size by Application (M USD)
Table 78. Middle East and Africa Diagnostic Nuclear Drug Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa Diagnostic Nuclear Drug Market Size (M USD) by Application (2020-2033)
Table 80. Global Diagnostic Nuclear Drug Production (K MT) by Region(2020-2025)
Table 81. Global Diagnostic Nuclear Drug Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Diagnostic Nuclear Drug Revenue Market Share by Region (2020-2025)
Table 83. Global Diagnostic Nuclear Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America Diagnostic Nuclear Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe Diagnostic Nuclear Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan Diagnostic Nuclear Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China Diagnostic Nuclear Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global Diagnostic Nuclear Drug Sales by Type (K MT)
Table 89. Global Diagnostic Nuclear Drug Market Size by Type (M USD)
Table 90. Global Diagnostic Nuclear Drug Sales (K MT) by Type (2020-2033)
Table 91. Global Diagnostic Nuclear Drug Sales Market Share by Type (2020-2033)
Table 92. Global Diagnostic Nuclear Drug Market Size (M USD) by Type (2020-2033)
Table 93. Global Diagnostic Nuclear Drug Market Size Share by Type (2020-2033)
Table 94. Global Diagnostic Nuclear Drug Sales (K MT) by Application
Table 95. Global Diagnostic Nuclear Drug Market Size by Application(M USD)
Table 96. Global Diagnostic Nuclear Drug Sales by Application (2020-2033) & (K MT)
Table 97. Global Diagnostic Nuclear Drug Sales Market Share by Application (2020-2033)
Table 98. Global Diagnostic Nuclear Drug Market Size by Application (2020-2033) & (M USD)
Table 99. Global Diagnostic Nuclear Drug Market Share by Application (2020-2033)
Table 100. Global Diagnostic Nuclear Drug Sales Growth Rate by Application (2020-2033)
Table 101. Cardinal Health Basic Information
Table 102. Cardinal Health Diagnostic Nuclear Drug Product Overview
Table 103. Cardinal Health Diagnostic Nuclear Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. Cardinal Health Business Overview
Table 105. Cardinal Health SWOT Analysis
Table 106. Cardinal Health Recent Developments
Table 107. GE Healthcare Basic Information
Table 108. GE Healthcare Diagnostic Nuclear Drug Product Overview
Table 109. GE Healthcare Diagnostic Nuclear Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. GE Healthcare Business Overview
Table 111. GE Healthcare SWOT Analysis
Table 112. GE Healthcare Recent Developments
Table 113. Curium Pharma Basic Information
Table 114. Curium Pharma Diagnostic Nuclear Drug Product Overview
Table 115. Curium Pharma Diagnostic Nuclear Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Curium Pharma Business Overview
Table 117. Curium Pharma SWOT Analysis
Table 118. Curium Pharma Recent Developments
Table 119. Jubilant Pharma Basic Information
Table 120. Jubilant Pharma Diagnostic Nuclear Drug Product Overview
Table 121. Jubilant Pharma Diagnostic Nuclear Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Jubilant Pharma Business Overview
Table 123. Jubilant Pharma Recent Developments
Table 124. Bracco Imaging Basic Information
Table 125. Bracco Imaging Diagnostic Nuclear Drug Product Overview
Table 126. Bracco Imaging Diagnostic Nuclear Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Bracco Imaging Business Overview
Table 128. Bracco Imaging Recent Developments
Table 129. Novartis Basic Information
Table 130. Novartis Diagnostic Nuclear Drug Product Overview
Table 131. Novartis Diagnostic Nuclear Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. Novartis Business Overview
Table 133. Novartis Recent Developments
Table 134. SIEMENS Basic Information
Table 135. SIEMENS Diagnostic Nuclear Drug Product Overview
Table 136. SIEMENS Diagnostic Nuclear Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. SIEMENS Business Overview
Table 138. SIEMENS Recent Developments
Table 139. China Isotope and Radiation Basic Information
Table 140. China Isotope and Radiation Diagnostic Nuclear Drug Product Overview
Table 141. China Isotope and Radiation Diagnostic Nuclear Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. China Isotope and Radiation Business Overview
Table 143. China Isotope and Radiation Recent Developments
Table 144. Dongcheng Basic Information
Table 145. Dongcheng Diagnostic Nuclear Drug Product Overview
Table 146. Dongcheng Diagnostic Nuclear Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. Dongcheng Business Overview
Table 148. Dongcheng Recent Developments
Table 149. Lantheus Basic Information
Table 150. Lantheus Diagnostic Nuclear Drug Product Overview
Table 151. Lantheus Diagnostic Nuclear Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 152. Lantheus Business Overview
Table 153. Lantheus Recent Developments
Table 154. Eli Lilly Basic Information
Table 155. Eli Lilly Diagnostic Nuclear Drug Product Overview
Table 156. Eli Lilly Diagnostic Nuclear Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 157. Eli Lilly Business Overview
Table 158. Eli Lilly Recent Developments
List of Figures
Figure 1. Product Picture of Diagnostic Nuclear Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Diagnostic Nuclear Drug Market Size (M USD), 2024-2033
Figure 5. Global Diagnostic Nuclear Drug Market Size (M USD) (2020-2033)
Figure 6. Global Diagnostic Nuclear Drug Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Diagnostic Nuclear Drug Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Diagnostic Nuclear Drug Product Life Cycle
Figure 13. Diagnostic Nuclear Drug Sales Share by Manufacturers in 2024
Figure 14. Global Diagnostic Nuclear Drug Revenue Share by Manufacturers in 2024
Figure 15. Diagnostic Nuclear Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Diagnostic Nuclear Drug Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Diagnostic Nuclear Drug Revenue in 2024
Figure 18. Industry Chain Map of Diagnostic Nuclear Drug
Figure 19. Global Diagnostic Nuclear Drug Market PEST Analysis
Figure 20. Global Diagnostic Nuclear Drug Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Diagnostic Nuclear Drug Market Size by Region
Figure 27. Global Diagnostic Nuclear Drug Market Size Market Share by Region (2020-2033)
Figure 28. Global Diagnostic Nuclear Drug Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Diagnostic Nuclear Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America Diagnostic Nuclear Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Diagnostic Nuclear Drug Market Size (M USD) by Country
Figure 33. USA Diagnostic Nuclear Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA Diagnostic Nuclear Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Diagnostic Nuclear Drug Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada Diagnostic Nuclear Drug Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Diagnostic Nuclear Drug Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Diagnostic Nuclear Drug Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Diagnostic Nuclear Drug Market Size (M USD)by Type
Figure 40. North America Diagnostic Nuclear Drug Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Diagnostic Nuclear Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe Diagnostic Nuclear Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Diagnostic Nuclear Drug Market Size (M USD) by Country
Figure 45. Germany Diagnostic Nuclear Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany Diagnostic Nuclear Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Diagnostic Nuclear Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France Diagnostic Nuclear Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Diagnostic Nuclear Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. Diagnostic Nuclear Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Diagnostic Nuclear Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy Diagnostic Nuclear Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Diagnostic Nuclear Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain Diagnostic Nuclear Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Diagnostic Nuclear Drug Market Size (M USD) by Type
Figure 56. Europe Diagnostic Nuclear Drug Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Diagnostic Nuclear Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific Diagnostic Nuclear Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Diagnostic Nuclear Drug Market Size (M USD) by Country
Figure 61. China Diagnostic Nuclear Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China Diagnostic Nuclear Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Diagnostic Nuclear Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan Diagnostic Nuclear Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Diagnostic Nuclear Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea Diagnostic Nuclear Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Diagnostic Nuclear Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India Diagnostic Nuclear Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Diagnostic Nuclear Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia Diagnostic Nuclear Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Diagnostic Nuclear Drug Market Size (M USD) by Type
Figure 72. Asia-Pacific Diagnostic Nuclear Drug Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Diagnostic Nuclear Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America Diagnostic Nuclear Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Diagnostic Nuclear Drug Market Size (M USD) by Country
Figure 77. Brazil Diagnostic Nuclear Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil Diagnostic Nuclear Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Diagnostic Nuclear Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina Diagnostic Nuclear Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Diagnostic Nuclear Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia Diagnostic Nuclear Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Diagnostic Nuclear Drug Market Size (M USD) by Type
Figure 84. South America Diagnostic Nuclear Drug Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Diagnostic Nuclear Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa Diagnostic Nuclear Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Diagnostic Nuclear Drug Market Size (M USD) by Country
Figure 89. Saudi Arabia Diagnostic Nuclear Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia Diagnostic Nuclear Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Diagnostic Nuclear Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE Diagnostic Nuclear Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Diagnostic Nuclear Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt Diagnostic Nuclear Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Diagnostic Nuclear Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria Diagnostic Nuclear Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Diagnostic Nuclear Drug Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa Diagnostic Nuclear Drug Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Diagnostic Nuclear Drug Market Size (M USD) by Type
Figure 100. Middle East and Africa Diagnostic Nuclear Drug Market Size (M USD) by Application
Figure 101. Global Diagnostic Nuclear Drug Production Market Share by Region (2020-2025)
Figure 102. North America Diagnostic Nuclear Drug Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Diagnostic Nuclear Drug Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Diagnostic Nuclear Drug Production (K MT) Growth Rate (2020-2025)
Figure 105. China Diagnostic Nuclear Drug Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Diagnostic Nuclear Drug Market Size by Type (M USD)
Figure 108. Sales Market Share of Diagnostic Nuclear Drug by Type (2020-2033)
Figure 109. Sales Market Share of Diagnostic Nuclear Drug by Type in 2024
Figure 110. Market Size Share of Diagnostic Nuclear Drug by Type (2020-2033)
Figure 111. Market Size Share of Diagnostic Nuclear Drug by Type in 2024
Figure 112. Global Diagnostic Nuclear Drug Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Diagnostic Nuclear Drug Market Size by Application(M USD)
Figure 115. Global Diagnostic Nuclear Drug Market Share by Application
Figure 116. Global Diagnostic Nuclear Drug Sales Market Share by Application (2020-2033)
Figure 117. Global Diagnostic Nuclear Drug Sales Market Share by Application in 2024
Figure 118. Global Diagnostic Nuclear Drug Market Share by Application (2020-2033)
Figure 119. Global Diagnostic Nuclear Drug Market Share by Application in 2024
Figure 120. Global Diagnostic Nuclear Drug Sales Growth Rate by Application (2020-2033)